Innovation Pharmaceuticals Inc (IPIX)

[monkeyplay1]

So using BK's 15% market penetration rate across the board, we reached $8.4 billions annual sale potential.

Conventional market valuation number is 5 time annual sale, therefore we have a market valuation of 8.4X5=$42 billions.

By industry average, for a breakthrough technology in drug/life science, the royalty for "ready for launch" product is 30% (adjusted by profit margin).

In other words, we could expect 0.3X42=$12.6 billions royalty income for CTIX.

In my experience, this $12.6 won't all reflect in stock price. CTIX is a company in developing. It has to yield some interests to others, internally and externally. I believe 70% of stock price realization is more realistic, based on my experience. That is to say that we could expect 0.7x12.6=$8.82 billions market cap for B alone, within next 3 years according to Leo' workaholic tempo.

But, I actually believe BK's 15% market penetration rate is way too low. I expected a 30% market penetration rate a minimum. We could easily see a $15 billion market cap for Brilacidin alone. That'll give us $136 apiece for the stock price.